Lifevantage Insider Trades
NASDAQ: LFVNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Lifevantage insider activity
Over the last 12 months, Lifevantage insiders reported 3 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Aure Carl (Chief Financial Officer) reporting a transaction in 35,749 shares on Oct 7, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put LFVN's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
LFVN insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 7, 2026 | Cunningham KristenChief Sales Officer | Award | 32,850 | — | Form 4 |
| Oct 7, 2026 | Moorehead TerrencePresident and CEO | Award | 193,237 | — | Form 4 |
| Oct 7, 2026 | Aure CarlChief Financial Officer | Award | 35,749 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4